AU2001290273A1 - Paramyxovirus vector for transferring foreign gene into skeletal muscle - Google Patents

Paramyxovirus vector for transferring foreign gene into skeletal muscle

Info

Publication number
AU2001290273A1
AU2001290273A1 AU2001290273A AU9027301A AU2001290273A1 AU 2001290273 A1 AU2001290273 A1 AU 2001290273A1 AU 2001290273 A AU2001290273 A AU 2001290273A AU 9027301 A AU9027301 A AU 9027301A AU 2001290273 A1 AU2001290273 A1 AU 2001290273A1
Authority
AU
Australia
Prior art keywords
skeletal muscle
foreign gene
paramyxovirus vector
transferring foreign
transferring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001290273A
Inventor
Mamoru Hasegawa
Masayuki Hukumura
Mitsuyo Maeda
Akihiro Shiotani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dnavec Research Inc
Original Assignee
Dnavec Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dnavec Research Inc filed Critical Dnavec Research Inc
Publication of AU2001290273A1 publication Critical patent/AU2001290273A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18841—Use of virus, viral particle or viral elements as a vector
    • C12N2760/18843—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2001290273A 2000-10-06 2001-09-26 Paramyxovirus vector for transferring foreign gene into skeletal muscle Abandoned AU2001290273A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000308533 2000-10-06
JP2000-308533 2000-10-06
PCT/JP2001/008372 WO2002031138A1 (en) 2000-10-06 2001-09-26 Paramyxovirus vector for transferring foreign gene into skeletal muscle

Publications (1)

Publication Number Publication Date
AU2001290273A1 true AU2001290273A1 (en) 2002-04-22

Family

ID=18788823

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001290273A Abandoned AU2001290273A1 (en) 2000-10-06 2001-09-26 Paramyxovirus vector for transferring foreign gene into skeletal muscle

Country Status (8)

Country Link
US (1) US20040053877A1 (en)
EP (1) EP1333088A4 (en)
JP (1) JPWO2002031138A1 (en)
KR (1) KR20030042003A (en)
CN (1) CN1526014A (en)
AU (1) AU2001290273A1 (en)
CA (1) CA2424992A1 (en)
WO (1) WO2002031138A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997016539A1 (en) * 1995-11-01 1997-05-09 Dnavec Research Inc. Recombinant sendai virus
US6490775B1 (en) * 1999-04-23 2002-12-10 Veri-Tek Inc. Press operation verification system
US7226786B2 (en) * 1999-05-18 2007-06-05 Dnavec Research Inc. Envelope gene-deficient Paramyxovirus vector
AU6872000A (en) 1999-09-06 2001-04-10 Dnavec Research Inc. Paramyxoviruses having modified transcription initiation sequence
US7314614B1 (en) 1999-11-02 2008-01-01 Dnavec Research, Inc. Recombinant sendai virus vector for introducing exogenous genes to airway epithelia
JPWO2001072340A1 (en) 2000-03-30 2004-01-08 株式会社ディナベック研究所 AIDS virus vaccine using Sendai virus vector
ES2430991T3 (en) * 2000-06-01 2013-11-22 Dnavec Research Inc. Pseudotype retroviral vector containing membrane protein that has hemagglutinin activity
WO2002000264A1 (en) * 2000-06-27 2002-01-03 Dnavec Research Inc. Virus vector for transferring gene into renal cells
JP2002142770A (en) * 2000-11-08 2002-05-21 Dnavec Research Inc Paramyxovirus vector for transporting gene to circulatory system
EP1344829B1 (en) * 2000-11-27 2008-04-23 Dnavec Research Inc. Paramyxovirus vector encoding fibroblast growth factor 2 (fgf2) and use thereof
KR20040104673A (en) * 2002-04-30 2004-12-10 가부시키가이샤 디나벡크 겐큐쇼 Drug- or gene-carrier composition having lowered hemagglutinin activity
AU2003261931A1 (en) * 2002-09-04 2004-03-29 Dnavec Research Inc. Process for producing virus vector containing membrane protein having sialic acid-binding activitiy in envelope with the use of gram-positive bacterium-origin neuraminidase
US20060104950A1 (en) * 2002-10-24 2006-05-18 Shinji Okano Methods of Tranducing genes into T cells
AU2004252377A1 (en) * 2003-06-30 2005-01-06 Dnavec Research Inc. Minus strand RNA virus vector carrying gene modified in high mutation region
WO2005004420A2 (en) 2003-07-02 2005-01-13 Mitsubishi Electric Research Laboratories, Inc. Method and apparatus for routing data in a personal area network
KR20060129013A (en) * 2004-01-13 2006-12-14 가부시키가이샤 디나벡크 겐큐쇼 Gene therapy for tumor using minus-strand rna virus vector encoding immunostimulating cytokine
CN1934257A (en) * 2004-01-22 2007-03-21 株式会社载体研究所 Process for producing virus vector
JPWO2005116194A1 (en) * 2004-05-25 2008-04-03 独立行政法人理化学研究所 Myoblast or myoblast-like cell culture method for in vitro myofiber formation
CN101351557A (en) * 2005-10-28 2009-01-21 生物载体株式会社 Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with RNA virus or DNA virus spike protein
JP6439690B2 (en) * 2013-07-12 2018-12-19 石原産業株式会社 Composition for gene transfer into cells

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5155214A (en) * 1984-03-05 1992-10-13 The Salk Institute For Biological Studies Basic fibroblast growth factor
US4994559A (en) * 1985-12-17 1991-02-19 Synergen, Inc. Human basic fibroblast growth factor
FR2681786A1 (en) * 1991-09-27 1993-04-02 Centre Nat Rech Scient RECOMBINANT VECTORS OF VIRAL ORIGIN, PROCESS FOR OBTAINING SAME AND THEIR USE FOR THE EXPRESSION OF POLYPEPTIDES IN MUSCLE CELLS.
EP1321526A3 (en) * 1992-11-18 2003-07-02 Arch Development Corporation Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle
ES2210273T5 (en) * 1994-07-18 2010-03-29 Conzelmann, Karl-Klaus, Prof. Dr. VIRUS WITH NEGATIVE CHAIN NON-SEGMENTED RECOMBINANT INFECTIVE.
ATE181112T1 (en) * 1995-08-09 1999-06-15 Schweiz Serum & Impfinst CDNA CORRESPONDING TO THE GENOME OF MINUTE-STANDED RNA VIRUSES AND METHOD FOR PRODUCING INFECTIOUS MINUTE-STANDED RNA VIRUSES
US6121246A (en) * 1995-10-20 2000-09-19 St. Elizabeth's Medical Center Of Boston, Inc. Method for treating ischemic tissue
EP0864645B9 (en) * 1995-10-31 2006-03-22 Dnavec Research Inc. Negative-strand rna virus vector having autonomously replicating activity
WO1997016539A1 (en) * 1995-11-01 1997-05-09 Dnavec Research Inc. Recombinant sendai virus
JP3847366B2 (en) * 1996-02-22 2006-11-22 アンジェスＭｇ株式会社 Stationary mitotic cell growth agent using antisense oligonucleotide
WO1997031656A1 (en) * 1996-03-01 1997-09-04 Dnavec Research Inc. Composition for stably introducing genes into liver cells and method of introducing genes by using said composition
US6828138B1 (en) * 1998-08-11 2004-12-07 Dnavec Research Inc. Recombinant sendai virus vector including a gene encoding a chemokine
EP1013667B1 (en) * 1998-11-09 2006-10-11 Nippon Biologicals, Inc. Process for preparation of cytokine using a sendai virus expression system
JP2000253876A (en) * 1999-03-08 2000-09-19 Dnavec Research Inc Vaccine using sendai virus vector, and vaccine protein
US7226786B2 (en) * 1999-05-18 2007-06-05 Dnavec Research Inc. Envelope gene-deficient Paramyxovirus vector
US20030166252A1 (en) * 1999-05-18 2003-09-04 Kaio Kitazato Paramyxovirus-derived RNP
AU6872000A (en) * 1999-09-06 2001-04-10 Dnavec Research Inc. Paramyxoviruses having modified transcription initiation sequence
US7314614B1 (en) * 1999-11-02 2008-01-01 Dnavec Research, Inc. Recombinant sendai virus vector for introducing exogenous genes to airway epithelia
US20030170210A1 (en) * 2000-01-19 2003-09-11 Ichiro Masaki Use of paramyxovirus vector in gene transfer into blood vessel
JPWO2001072340A1 (en) * 2000-03-30 2004-01-08 株式会社ディナベック研究所 AIDS virus vaccine using Sendai virus vector
CA2322057A1 (en) * 2000-05-18 2001-11-18 Dnavec Research Inc. Paramyxovirus vectors used for transfer of foreign genes
ES2430991T3 (en) * 2000-06-01 2013-11-22 Dnavec Research Inc. Pseudotype retroviral vector containing membrane protein that has hemagglutinin activity
JP2002142770A (en) * 2000-11-08 2002-05-21 Dnavec Research Inc Paramyxovirus vector for transporting gene to circulatory system
KR20060129013A (en) * 2004-01-13 2006-12-14 가부시키가이샤 디나벡크 겐큐쇼 Gene therapy for tumor using minus-strand rna virus vector encoding immunostimulating cytokine

Also Published As

Publication number Publication date
CA2424992A1 (en) 2003-04-04
WO2002031138A1 (en) 2002-04-18
US20040053877A1 (en) 2004-03-18
EP1333088A4 (en) 2004-11-24
CN1526014A (en) 2004-09-01
KR20030042003A (en) 2003-05-27
EP1333088A1 (en) 2003-08-06
JPWO2002031138A1 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
AU2001290273A1 (en) Paramyxovirus vector for transferring foreign gene into skeletal muscle
AUPR464601A0 (en) Shapes vector
AU2001266337A1 (en) Virus vector for transferring gene into renal cells
AU2003278695A1 (en) Nucleic acid vectors
AU2001232054A1 (en) Vector
AU3758199A (en) Peptides for efficient gene transfer
GB0007651D0 (en) Gene sequence
HK1071002A1 (en) Charging system
AU2001264247A1 (en) GASC1 gene
AU2002221757A1 (en) Disconnectable buoy
AU5216601A (en) Reconnaissance system
AU2001288839A1 (en) Self-rearranging dna vectors
AU2472501A (en) Methods for protein transfer
AU2000249592A1 (en) Keel assemblies
AUPQ749100A0 (en) New epilespy gene
AU2003271883A1 (en) Vector system
GB2362383B (en) Gene expression system
AU4672401A (en) Vectors
AUPQ521300A0 (en) Improved kit handling system
AU5498800A (en) Stem cells derived from skeletal muscle
AU2002221623A1 (en) Gene 4
AU2002306951A1 (en) Gene regulation ii
AU2002230889A1 (en) Target enzymes
AU2001264554A1 (en) Excitatory amino acid receptor modulators
AU2001233702A1 (en) Disease-associated gene